Reports

Drug name	NICE TAs	Comments
Edoxaban#Amber	TA355 - Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation TA354 - Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism	Specialist initiation - For the treatment and secondary prevention of DVT and/or PE - use in line with NICE and supported by RICaD Anticoagulant Initiation Flowchart for Anticoagulation in Atrial Fibrillation
Eltrombopag tablets	TA293 - Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura
Eluxadoline (Truberzi®)	TA471 - Eluxadoline for treating irritable bowel syndrome with diarrhoea	To be used in line with NICE TA 471. Specialist initiation, and transfer prescribing to GP using RICaD (in development).
Empagliflozin	TA390 - Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
Empagliflozin (Jardiance®)	TA773 - Empagliflozin for treating chronic heart failure with reduced ejection fraction
Empaglifozin#Amber	TA929 - Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
Empaglifozin#Green	TA942 - Empagliflozin for treating chronic kidney disease
Encorafenib (Braftovi®)	TA668 - Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer
Encorafenib with binimetinib	TA562 - Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanoma
Entrectinib	TA643 - Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer TA644 - Entrectinib for treating NTRK fusion-positive solid tumours

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports